SCHEMBL7912658

SCHEMBL7912658

CCOC(=O)CN1C(=O)C(CCC2(C)OCCO2)CC1Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MYC P01106 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7912662 1.00 ALDH1A1 (0.38) ALDH1A1LMNAGAASMN1; SMN2CYP1A2
SCHEMBL7456327 0.83 EHMT2 (0.36) GAACYP2C19CYP3A4
SCHEMBL7910576 0.81 ALDH1A1 (0.39) ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL7910573 0.81 ALDH1A1 (0.39) ALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL7555364 0.76 CYP3A4 (0.36) GAACYP2C19CYP3A4
SCHEMBL7902405 0.76 CYP3A4 (0.36) GAACYP2C19CYP3A4
SCHEMBL7455237 0.74 EHMT2 (0.35) ALDH1A1GAASMN1; SMN2CYP2C19CYP3A4
SCHEMBL7459592 0.74 EHMT2 (0.35) ALDH1A1GAASMN1; SMN2CYP2C19CYP3A4
SCHEMBL7909668 0.72 ITGAV (0.47)
SCHEMBL7909673 0.72 ITGAV (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211184-B1 TETRAHYDRO-PYRAZINE OR PYRIMIDINE DERIVATIVES; VITRONECTIN RECEPTOR ANTAGONIST; OSTEOPOROSIS; ANTIINFLAMMATORY, ANTITUMOR AGENTS; ANGIOGENESIS AND RESTENOSIS INHIBITORS MERCK & CO., INC. 2001-04-03 US disclosed
US-5981546-A Integrin antagonists MERCK & CO., INC. (US) 1999-11-09 US disclosed